DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies.
The DEA will hold hearings on whether to lessen restrictions on marijuana where it would be in the same class of drugs as anabolic steroids.
By Terry Hacienda, The Fresh Toast It has been clear the DEA It has been clear Anne Milgram, the head of the D ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling ...
As the federal government considers loosening restrictions on marijuana, the Drug Enforcement Administration is scheduled to convene a court hearing to flesh out the Biden administration’s ...
The motion, which asks the DOJ to take over moving cannabis down the list, argues the DEA has "stacked the deck" against ...
The cannabis industry is concerned about the direction of regulations – and the DEA is still against the plant.
DEA and anti-cannabis group must respond to allegations of unlawful talks by November 25. Legal tensions rise ahead of ...